Translational Fidelity in Eukaryotes

真核生物的翻译保真度

基本信息

  • 批准号:
    7849893
  • 负责人:
  • 金额:
    $ 24.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2011-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT With the availability of atomic scale structures of ribosomes, the next critical task is to link ribosome structure with biological function. At the biological level, we have been exploring how ribosomes recognize termination codons and maintain translational reading frame using translational recoding signals of viral origin. Viral recoding is important for virus propagation, and their mRNA-based recoding signals have proved to be of great utility in elucidating the molecular mechanisms underlying these essential tasks. These studies have been based on the yeast Saccharomyces cerevisiae model eukaryotic organism because it provides researchers with the most advanced, diverse, and robust toolbox available. Further, we have built upon this foundation to develop a robust and synergistic combination of molecular genetic, biochemical, structural, and molecular modeling tools. This has enabled us to show that both the biophysical interactions between ribosomal proteins, rRNAs and tRNAs, and the biochemical properties of ribosome-associated enzymatic activities are important for proper reading frame maintenance and stop codon recognition. On a broader scale, our work is defining the allosteric communication pathways that connect and coordinate different functional centers of the ribosome with one another. The broad goal of this proposal is to further define how ribosome structure influences function. Aim 1 will determine the effects of targeted mutations on yeast ribosome structure and function. Specifically, reverse genetics approaches will be applied to define the functions of specific ribosomal proteins and ribosomal RNAs. These studies include expansion to examine the effects of two ribosome-associated mutations in mammalian systems. The second aim will characterize the interactions between ribosomes the Cricket Paralysis Virus Internal Ribosome Entry Signal (CRPV IRES), and the HIV-1 programmed -1 ribosomal frameshift signal. The proposed collaborations represent logical expansions of our work into new and exciting areas. We also anticipate that during the course of the proposed studies, breakthroughs will continue to be made in the area of ribosome structure, and that new discoveries relevant to ribosomes and disease will be unveiled. The proposed program will position us to quickly capitalize on these, providing a strong foundation for new and unanticipated discovery opportunities. In the end, this work will make significant contributions to the scientific and clinical communities by both deepening our understanding of the relationship between ribosome structure and function, while broadening our view of translational fidelity and disease. PROJECT NARRATIVE Proliferating cells, be they embryonic cells busily creating new persons, T-cells fighting off infection, or cancer cells overwhelming the patient, absolutely require large numbers of highly accurate ribosomes to meet their needs for synthesis of new proteins. Ribosomes, the central component of this process, are complex biological nanomachines composed of many protein and RNA molecules, and the overall goal of the proposed research is to begin to understand how the atomic scale structure of the ribosome ultimately determines its function. A deeper understanding of the relationship between ribosome structure and function will aid the rational design of new classes of drugs designed to target a diverse array of clinical applications including antiviral and antibacterial agents, as well as drugs targeting a diverse array of cancers, developmental disorders, and other critical diseases afflicting society.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jonathan D Dinman其他文献

Jonathan D Dinman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jonathan D Dinman', 18)}}的其他基金

Regulation of programmed -1 ribosomal frameshifting by micro-RNAs
micro-RNA 对程序性 -1 核糖体移码的调节
  • 批准号:
    9006443
  • 财政年份:
    2015
  • 资助金额:
    $ 24.87万
  • 项目类别:
Regulation of programmed -1 ribosomal frameshifting by micro-RNAs
micro-RNA 对程序性 -1 核糖体移码的调节
  • 批准号:
    9150632
  • 财政年份:
    2015
  • 资助金额:
    $ 24.87万
  • 项目类别:
Regulation of programmed -1 ribosomal frameshifting by micro-RNAs
micro-RNA 对程序性 -1 核糖体移码的调节
  • 批准号:
    9278237
  • 财政年份:
    2015
  • 资助金额:
    $ 24.87万
  • 项目类别:
X-linked Dyskeratosis Congenita and ribosomal frameshifting
X连锁先天性角化不良和核糖体移码
  • 批准号:
    8761841
  • 财政年份:
    2014
  • 资助金额:
    $ 24.87万
  • 项目类别:
X-linked Dyskeratosis Congenita and ribosomal frameshifting
X连锁先天性角化不良和核糖体移码
  • 批准号:
    8894573
  • 财政年份:
    2014
  • 资助金额:
    $ 24.87万
  • 项目类别:
Characterization of the SARSCoV frameshift signal
SARSCoV 移码信号的表征
  • 批准号:
    7884348
  • 财政年份:
    2006
  • 资助金额:
    $ 24.87万
  • 项目类别:
Characterization of the SARSCoV frameshift signal
SARSCoV 移码信号的表征
  • 批准号:
    7651192
  • 财政年份:
    2006
  • 资助金额:
    $ 24.87万
  • 项目类别:
Characterization of the SARS-CoV frameshift signal
SARS-CoV 移码信号的表征
  • 批准号:
    7253257
  • 财政年份:
    2006
  • 资助金额:
    $ 24.87万
  • 项目类别:
Characterization of the SARS-CoV frameshift signal
SARS-CoV 移码信号的表征
  • 批准号:
    7433287
  • 财政年份:
    2006
  • 资助金额:
    $ 24.87万
  • 项目类别:
Characterization of the SARSCoV frameshift signal
SARSCoV 移码信号的表征
  • 批准号:
    7139717
  • 财政年份:
    2006
  • 资助金额:
    $ 24.87万
  • 项目类别:

相似海外基金

New technologies for targeted delivery of anti-bacterial agents
抗菌药物靶向递送新技术
  • 批准号:
    1654774
  • 财政年份:
    2015
  • 资助金额:
    $ 24.87万
  • 项目类别:
    Studentship
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8416313
  • 财政年份:
    2012
  • 资助金额:
    $ 24.87万
  • 项目类别:
Targeting bacterial phosphatases for novel anti-bacterial agents.
针对细菌磷酸酶的新型抗菌剂。
  • 批准号:
    8298885
  • 财政年份:
    2012
  • 资助金额:
    $ 24.87万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了